Multimedialna platforma wiedzy medycznej Internetowa Księgarnia Medyczna Kalendarium Konferencji
Endokrynologia Polska
MENU
Shortcuts Submit an article Author Guidelines Polish Society of Endocrinology Reviewers 2022 Redeem voucher Abstracts, 5–7 May 2022, Gliwice

open access

Vol 69, No 2 (2018)
Review paper
Submitted: 2017-10-02
Accepted: 2017-10-09
Published online: 2018-03-29
View PDF Download PDF file
Get Citation

The content of this article is also available in the following languages:
Polski

Expression of follicle stimulating hormone receptors in intra-tumoral vasculature and in tumoral cells — the involvement in tumour progression and the perspectives of application in cancer diagnosis and therapy

Marek Pawlikowski (Łódź)1
DOI: 10.5603/EP.2018.0022
·
Pubmed: 29952426
·
Endokrynol Pol 2018;69(2):192-198.
Affiliations
  1. Uniwersytet Medyczny w Łodzi, Katedra Endokrynologii, Sterlinga 3, 91-414 Łódź, Poland

open access

Vol 69, No 2 (2018)
Review Article
Submitted: 2017-10-02
Accepted: 2017-10-09
Published online: 2018-03-29

Abstract

In normal conditions follicle stimulating hormone receptors (FSHR) are expressed in zona granulosa cells of the ovary and Sertoli cells of the testis. However, the ectopic expression of FSHR was recently discovered in intra-tumoral blood vessels endothelia and/or in tumoral cells of many extra-gonadal human tumors (particularly in endocrine tumours). The paper reviews the data concerning the appearance of ectopic FSHR in particular human neoplasms. The possible involvement of FSHR in tumor progression and the use of FSHR examination for diagnostic purposes is also reviewed. Finally, the putative role of FSHR as a new target in oncological therapy is also discussed.

Abstract

In normal conditions follicle stimulating hormone receptors (FSHR) are expressed in zona granulosa cells of the ovary and Sertoli cells of the testis. However, the ectopic expression of FSHR was recently discovered in intra-tumoral blood vessels endothelia and/or in tumoral cells of many extra-gonadal human tumors (particularly in endocrine tumours). The paper reviews the data concerning the appearance of ectopic FSHR in particular human neoplasms. The possible involvement of FSHR in tumor progression and the use of FSHR examination for diagnostic purposes is also reviewed. Finally, the putative role of FSHR as a new target in oncological therapy is also discussed.

Full Text:

View PDF Download PDF file
Get Citation

Keywords

follicle stimulating hormone receptor, ectopic expression, cancer markers, cancer progression, cancer treatment, follicle stimulating hormone antagonists

About this article
Title

Expression of follicle stimulating hormone receptors in intra-tumoral vasculature and in tumoral cells — the involvement in tumour progression and the perspectives of application in cancer diagnosis and therapy

Journal

Endokrynologia Polska

Issue

Vol 69, No 2 (2018)

Article type

Review paper

Pages

192-198

Published online

2018-03-29

Page views

2460

Article views/downloads

1826

DOI

10.5603/EP.2018.0022

Pubmed

29952426

Bibliographic record

Endokrynol Pol 2018;69(2):192-198.

Keywords

follicle stimulating hormone receptor
ectopic expression
cancer markers
cancer progression
cancer treatment
follicle stimulating hormone antagonists

Authors

Marek Pawlikowski (Łódź)

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Via MedicaWydawcą jest  VM Media Group sp. z o.o., Grupa Via Medica, ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl